Antibody-Drug Conjugates in Prostate Cancer: A Systematic Review

The prognosis in the setting of metastatic castration-resistant prostate cancer patients (mCRPC) remains limited. Therefore, novel treatment strategies remain an unmet need. Antibody-drug conjugates (ADC) emerged as a new drug concept with the potential to deliver a cytotoxic payload with limited of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardinha, Mariana, Palma dos Reis, Ana Filipa, Barreira, João Vasco, Fontes Sousa, Mário, Pacey, Simon, Luz, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983052/
https://www.ncbi.nlm.nih.gov/pubmed/36874351
http://dx.doi.org/10.7759/cureus.34490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983052/
https://www.ncbi.nlm.nih.gov/pubmed/36874351
http://dx.doi.org/10.7759/cureus.34490

Ejemplares similares